IBDEI368 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50635,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,50636,0)
 ;;=D63.8^^193^2497^22
 ;;^UTILITY(U,$J,358.3,50636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50636,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,50636,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,50636,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,50637,0)
 ;;=C22.3^^193^2497^27
 ;;^UTILITY(U,$J,358.3,50637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50637,1,3,0)
 ;;=3^Angiosarcoma of Liver
 ;;^UTILITY(U,$J,358.3,50637,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,50637,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,50638,0)
 ;;=D61.9^^193^2497^28
 ;;^UTILITY(U,$J,358.3,50638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50638,1,3,0)
 ;;=3^Aplastic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,50638,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,50638,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,50639,0)
 ;;=D56.1^^193^2497^30
 ;;^UTILITY(U,$J,358.3,50639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50639,1,3,0)
 ;;=3^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,50639,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,50639,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,50640,0)
 ;;=C83.79^^193^2497^32
 ;;^UTILITY(U,$J,358.3,50640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50640,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,50640,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,50640,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,50641,0)
 ;;=C83.70^^193^2497^33
 ;;^UTILITY(U,$J,358.3,50641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50641,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,50641,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,50641,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,50642,0)
 ;;=D09.0^^193^2497^40
 ;;^UTILITY(U,$J,358.3,50642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50642,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,50642,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,50642,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,50643,0)
 ;;=D06.9^^193^2497^41
 ;;^UTILITY(U,$J,358.3,50643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50643,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix
 ;;^UTILITY(U,$J,358.3,50643,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,50643,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,50644,0)
 ;;=D06.0^^193^2497^43
 ;;^UTILITY(U,$J,358.3,50644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50644,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,50644,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,50644,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,50645,0)
 ;;=D06.1^^193^2497^44
 ;;^UTILITY(U,$J,358.3,50645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50645,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,50645,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,50645,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,50646,0)
 ;;=D06.7^^193^2497^42
 ;;^UTILITY(U,$J,358.3,50646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50646,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,50646,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,50646,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,50647,0)
 ;;=D04.9^^193^2497^45
 ;;^UTILITY(U,$J,358.3,50647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50647,1,3,0)
 ;;=3^Carcinoma in Situ of Skin
 ;;^UTILITY(U,$J,358.3,50647,1,4,0)
 ;;=4^D04.9
 ;;^UTILITY(U,$J,358.3,50647,2)
 ;;=^5001925
 ;;^UTILITY(U,$J,358.3,50648,0)
 ;;=C91.11^^193^2497^48
